Page last updated: 2024-12-10

ct 2584

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID Source	ID
PubMed CID	3081346
CHEMBL ID	4297274
SCHEMBL ID	107843
MeSH ID	M0276372

Synonyms (20)

Synonym
1-(11-(dodecylamino)-10-hydroxyundecyl)-3,7-dihydro-3,7-dimethyl-1h-purine-2,6-dione
ct-2584
unii-67e5n3r22h
166981-13-1
1h-purine-2,6-dione, 1-(11-(dodecylamino)-10-hydroxyundecyl)-3,7-dihydro-3,7-dimethyl-
67e5n3r22h ,
ct 2584
1-[11-(dodecylamino)-10-hydroxyundecyl]-3,7-dimethylpurine-2,6-dione
SCHEMBL107843
1-(11-dodecylamino-10-hydroxyundecyl)-3,7-dimethylxanthine
DB13098
160944-05-8
1-[11-(dodecylamino)-10-hydroxyundecyl]-3,7-dimethyl-3,7-dihydro-1h-purine-2,6-dione
DTXSID60936432
Q27264116
1-(11-(dodecylamino)-10-hydroxyundecyl)-3,7-dimethyl-3,7-dihydro-1h-purine-2,6-dione
CHEMBL4297274
AKOS040748191
HY-118982
CS-0078256

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	0 (0.00)	18.7374
1990's	4 (57.14)	18.2507
2000's	3 (42.86)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.54

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

Metric	This Compound (vs All)
Research Demand Index	24.54 (24.57)
Research Supply Index	2.40 (2.92)
Research Growth Index	4.18 (4.65)
Search Engine Demand Index	20.59 (26.88)
Search Engine Supply Index	2.00 (0.95)

This Compound (24.54)

All Compounds (24.57)

Study Types

Publication Type	This drug (%)	All Drugs (%)
Trials	2 (25.00%)	5.53%
Reviews	0 (0.00%)	6.00%
Case Studies	0 (0.00%)	4.05%
Observational	0 (0.00%)	0.25%
Other	6 (75.00%)	84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Substance	Relationship Strength	Studies	Trials	Classes	Roles
propranolol Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.. propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.	2	1	0	naphthalenes; propanolamine; secondary amine	anti-arrhythmia drug; antihypertensive agent; anxiolytic drug; beta-adrenergic antagonist; environmental contaminant; human blood serum metabolite; vasodilator agent; xenobiotic
phosphatidylcholines Phosphatidylcholines: Derivatives of PHOSPHATIDIC ACIDS in which the phosphoric acid is bound in ester linkage to a CHOLINE moiety.	2.41	2	0	1,2-diacyl-sn-glycero-3-phosphocholine

Condition	Relationship Strength	Studies	Trials
Hepatocellular Carcinoma [description not available]	1.99	1	0
Cancer of Liver [description not available]	1.99	1	0
Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.	1.99	1	0
Liver Neoplasms Tumors or cancer of the LIVER.	1.99	1	0
Cancer of Prostate [description not available]	2.4	2	0
Sarcoma, Epithelioid [description not available]	2.4	2	0
Prostatic Neoplasms Tumors or cancer of the PROSTATE.	2.4	2	0
Sarcoma A connective tissue neoplasm formed by proliferation of mesodermal cells; it is usually highly malignant.	2.4	2	0
Benign Neoplasms [description not available]	4.35	2	2
Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.	4.35	2	2
Breast Cancer [description not available]	2	1	0
Cancer of Lung [description not available]	2	1	0
Breast Neoplasms Tumors or cancer of the human BREAST.	2	1	0
Lung Neoplasms Tumors or cancer of the LUNG.	2	1	0
Arrhythmia [description not available]	3.39	1	1
Lassitude [description not available]	3.79	2	1
Hematuria Presence of blood in the urine.	3.79	2	1
Allergic Reaction [description not available]	3.39	1	1
Blood Pressure, Low [description not available]	3.39	1	1
Emesis [description not available]	3.39	1	1
Heart Disease, Ischemic [description not available]	3.39	1	1
Arrhythmias, Cardiac Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction.	3.39	1	1
Fatigue The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli.	3.79	2	1
Hypersensitivity Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen.	3.39	1	1
Hypotension Abnormally low BLOOD PRESSURE that can result in inadequate blood flow to the brain and other vital organs. Common symptom is DIZZINESS but greater negative impacts on the body occur when there is prolonged depravation of oxygen and nutrients.	3.39	1	1
Nausea An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.	3.39	1	1
Proteinuria The presence of proteins in the urine, an indicator of KIDNEY DISEASES.	3.39	1	1
Vomiting The forcible expulsion of the contents of the STOMACH through the MOUTH.	3.39	1	1
Myocardial Ischemia A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).	3.39	1	1

chemdatabank.com